Cancer Drug Resistance
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Home Articles Special Issues Volumes Webinars Videos

Volume

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy

Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions <i>in vitro</i>

Intercellular transfer of multidrug resistance mediated by extracellular vesicles

Non-coding RNA and drug resistance in head and neck cancer

Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment

Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinoma

The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

The uniqueness of ABCB5 as a full transporter ABCB5FL and a half-transporter-like ABCB5β

Targeting NETosis: nature’s alarm system in cancer progression

Impact of genetic variants in the solute carrier (<i>SLC</i>) genes encoding drug uptake transporters on the response to anticancer chemotherapy

Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review

Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells

Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them

Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers

Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a

Emerging role of MYB transcription factors in cancer drug resistance

HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs

The therapeutic potential of circular RNA in triple-negative breast cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer

Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications

Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia

Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors

Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia

Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer

Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel

Targeting T regulatory (T<sub>reg</sub>) cells in immunotherapy-resistant cancers

Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties